Aethlon Medical (AEMD) Income from Continuing Operations (2010 - 2026)
Aethlon Medical's (AEMD) quarterly Income from Continuing Operations came in at 38581162.0 in Q1 2026, down 5.99% YoY from 41037752.95 in Q1 2025, and down 1767.82% on a QoQ basis from 2065576.0 in Q4 2025.
Aethlon Medical (AEMD) Income from Continuing Operations (2010 - 2026) Analysis & Trends
Aethlon Medical (AEMD) has 17 years of Income from Continuing Operations data on file, last reported at 38581162.0 in Q1 2026.
- Quarterly Income from Continuing Operations fell 5.99% year-over-year to 38581162.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 43921736.0 (down 0.51% YoY) and the FY2026 annual result came in at 43801667.0, down 0.81% from the prior year.
- Income from Continuing Operations fell to 38581162.0 in Q1 2026, from 2065576.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 1513830.0 in Q3 2025 to a low of 38581162.0 in Q1 2026.
- A 5-year average of 12110349.88 and a median of 3036891.0 in 2023 frame the typical range for Income from Continuing Operations.
- Annual changes were most pronounced in 2022 — Income from Continuing Operations plunged 1264.34% — and 2025, when it surged 47.77%.
- Tracing AEMD's Income from Continuing Operations over 5 years: stood at 2849753.0 in 2022, then decreased by 21.35% to 3458170.0 in 2023, then surged by 47.15% to 1827804.0 in 2024, then fell by 13.01% to 2065576.0 in 2025, then slumped by 1767.82% to 38581162.0 in 2026.
- The last three Income from Continuing Operations figures came in at 38581162.0 (Q1 2026), 2065576.0 (Q4 2025), and 1513830.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Aethlon Medical | 1.08 Mn | 1.08 Mn | - | -1.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.59 Mn |
| Mar 31, 2026 | -38.58 Mn |
| Dec 31, 2025 | -2.07 Mn |
| Sep 30, 2025 | -1.51 Mn |
| Jun 30, 2025 | -1.76 Mn |
| Mar 31, 2025 | -36.40 Mn |
| Dec 31, 2024 | -1.83 Mn |
| Sep 30, 2024 | -2.90 Mn |
| Jun 30, 2024 | -2.57 Mn |
| Mar 31, 2024 | -35.69 Mn |
| Dec 31, 2023 | -3.46 Mn |
| Sep 30, 2023 | -3.04 Mn |
| Jun 30, 2023 | -3.28 Mn |
| Mar 31, 2023 | -32.49 Mn |
| Dec 31, 2022 | -2.85 Mn |
| Sep 30, 2022 | -3.67 Mn |
| Jun 30, 2022 | -2.91 Mn |
| Mar 31, 2022 | -30.88 Mn |
| Dec 31, 2021 | -2.53 Mn |
| Sep 30, 2021 | -2.62 Mn |